Name: UMIN ID:
Unique ID issued by UMIN | UMIN000001665 |
---|---|
Receipt number | R000002013 |
Scientific Title | Effect of drug metabolizing enzyme gene polymorphism on selective estrogen receptor modulator pharmacokinetics in breast cancer (JBCRG-12) |
Date of disclosure of the study information | 2009/02/01 |
Last modified on | 2021/08/13 16:07:54 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/01/28 13:54:36 | ||
2 | Update | 2010/01/15 17:14:45 | Organization Organization Category of Funding Organization Co-sponsor Co-sponsor Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
3 | Update | 2010/01/15 17:18:58 | Institute Institute |
|
4 | Update | 2010/01/20 11:15:13 | UMIN ID1 |
|
5 | Update | 2010/01/27 16:03:46 | Public title Public title |
|
6 | Update | 2010/07/28 11:08:26 | Recruitment status |
|
7 | Update | 2010/07/28 11:10:15 | Name of person sending information Organization Division name Address Address |
|
8 | Update | 2010/09/22 15:48:25 | Recruitment status |
|
9 | Update | 2010/12/02 22:29:43 | Study ID_1 |
|
10 | Update | 2011/01/28 10:48:49 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
11 | Update | 2011/11/28 15:27:36 | Institute Institute Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
12 | Update | 2011/11/28 15:46:41 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
13 | Update | 2012/05/15 16:54:10 | Institutions |
|
14 | Update | 2012/09/12 15:51:51 | Recruitment status |
|
15 | Update | 2013/06/17 16:28:31 | Acronym Acronym |
|
16 | Update | 2013/06/17 16:29:21 | Institute Organization |
|
17 | Update | 2015/01/28 11:30:32 | Organization Organization Division name Division name TEL Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name TEL |
|
18 | Update | 2016/05/15 14:11:22 | Email Name of primary person or sponsor Organization |
|
19 | Update | 2016/08/04 09:52:08 | Recruitment status Publication of results |
|
20 | Update | 2018/08/23 17:32:46 | Acronym |
|
21 | Update | 2019/11/21 16:58:59 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address Last name of contact person Last name of contact person Zip code Address Address Homepage URL Address Organization Organization Address Address Tel |
|
22 | Update | 2019/11/21 17:08:04 | Publication of results Number of participants that the trial has enrolled |
|
23 | Update | 2021/08/06 09:30:57 | URL releasing protocol URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Adverse events Adverse events Outcome measures Outcome measures |
|
24 | Update | 2021/08/13 16:07:54 | Participant flow Participant flow |